Date of announcement 2022/03/14
Time of announcement 19:19:24
Date of events 2022/03/14
To which item it meets paragraph 20

1.Date of occurrence of the event:2022/03/14
2.Date of the original announcement and reporting:2021/11/18
3.Summary of the content originally announced and reported:
The board, on November 18, 2021, approved that GM may invest up to US$15M
in the non-voting CPS issued by Medtech Holdings, indirectly invest into
the mainland Chinese enterprise (“Approved Investment”).
4.Reason for change and its main content:
Due to structure change of the deal, the Board, on March 14, 2022, approved
that the Approved Investment will not be performed.
5.Effect on the Company's finance and business after the change:None
6.Any other matters that need to be specified:
1) “GM” is short for “CDIB Global Markets Limited”
2) “Medtech Holdings” is short for “CDIB Medtech Holdings Limited”
3) “CPS” is short for Convertible Preferred Shares
4) At the same board meeting on March 14, 2022, the board also approved
that GM may invest up to US$10 million via Mezzanine Convertible Note
issued by Medtech Holdings.